Skip to main content
SpringerLink
Log in

Prenatal Considerations After Oocyte Donation

  • Chapter
  • First Online:
Principles of Oocyte and Embryo Donation

  • 1073 Accesses

Abstract

The number of pregnancies conceived through oocyte donation is on the rise. In 2008, approximately 12 % of all advanced reproductive technology (ART) cycles involved oocyte donation – an increase from previous years. While routine antenatal care may be appropriate for many of these patients, the indication for oocyte donation may dictate specific prenatal considerations. Once a pregnancy is established through oocyte donation, a healthy woman should be managed as any other gravid woman – with regular prenatal visits, routine prenatal labs, and appropriate ultrasound screening. However, patients who use oocyte donation as a means for achieving pregnancy because of a preexisting condition may require more specialized obstetric care. Both general and condition-specific risks should be considered when caring for women who conceive through oocyte donation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sauer MV, Kavic SM. Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy. Repro Biomed. 2006;12(2):153–62.

    Article  Google Scholar 

  2. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. 2008 annual report: assisted reproductive technology success rates. www.cdc.gov/art. December 2010.

  3. Sauer MV, Paulson RJ, Lobo RA. Oocyte donation to women of advanced reproductive age: pregnancy results and obstetrical outcomes in patients 45 years and older. Hum Reprod. 1996;11(11):2540–3.

    Article  PubMed  CAS  Google Scholar 

  4. Soderstrom-Anttila V. Pregnancy and child outcome after oocyte donation. Hum Reprod Update. 2001;7(1): 28–32.

    Article  PubMed  CAS  Google Scholar 

  5. Wiggins D, Main E. Outcomes of pregnancies achieved by donor egg in vitro fertilization – a comparison with standard in vitro fertilization pregnancies. Am J Obstet Gynecol. 2005;192:2002–8.

    Article  PubMed  Google Scholar 

  6. Pecks U, Maass N, Neulen J. Oocyte donation: a risk factor for pregnancy-induced hypertension. Dtsch Arztebl Int. 2011;108(3):23–31.

    PubMed  Google Scholar 

  7. Krieg S, Henne M, Westphal L. Obstetric outcomes in donor oocyte pregnancies compared with advanced maternal age in in vitro fertilization pregnancies. Fertil Steril. 2008;90(1):65–70.

    Article  PubMed  Google Scholar 

  8. Cleary-Goldman J, for the FASTER Consortium, et al. Impact of maternal age on obstetric outcome. Obstet Gynecol. 2005;105(5):983–90.

    Article  PubMed  Google Scholar 

  9. Heffner L. Advanced maternal age – how old is too old? N Engl J Med. 2004;351(19):1927–9.

    Article  PubMed  CAS  Google Scholar 

  10. Hoyert DL. Maternal mortality and related concepts. National Center for Health Statistics. Vital Health Stat. 2007;3(33):1–33.

    Google Scholar 

  11. Joseph KA, et al. The perinatal effects of delayed childbearing. Obstet Gynecol. 2005;105:1410–8.

    Article  PubMed  CAS  Google Scholar 

  12. Gilbert WM, Nesbitt TS, Danielsen B. Childbearing beyond age 40: pregnancy outcome in 24,032 cases. Obstet Gynecol. 1999;93:9–14.

    Article  PubMed  CAS  Google Scholar 

  13. Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse perinatal outcome. Obstet Gynecol. 2004;104(4):727–33.

    Article  PubMed  Google Scholar 

  14. Van Katwijk C, Peeters LH. Clinical aspects of pregnancy after the age of 35 years: a review of the literature. Hum Reprod Update. 1998;4(2):185–94.

    Article  PubMed  Google Scholar 

  15. Franz MB, Husslein PW. Obstetrical management of the older gravida. Womens Health (Lond Engl). 2010;6(3):463–8.

    Article  Google Scholar 

  16. Usta IM, Nassar A. Advanced maternal age. Part 1: obstetric complications. Am J Perinatol. 2008;25:521–34.

    Article  PubMed  Google Scholar 

  17. ACOG. Clinical management guidelines for obstetricians-gynecologists. ACOG practice bulletin. Management of stillbirth. Obstet Gynecol. 2009;113(3):748–61.

    Google Scholar 

  18. Huang L, Sauve R, Birkett N, Fergusson D, van Walraven C. Maternal age and risk of stillbirth. Can Med Assoc J. 2008;178(2):165–72.

    Article  Google Scholar 

  19. Fretts RC, Schmittdiel J, McLean FH. Increased maternal age and the risk for fetal death. N Engl J Med. 1995;333:953.

    Article  PubMed  CAS  Google Scholar 

  20. Reddy U, Laughon SK, Sun L, Troendle J, Willinger M, Zhang J. Prepregnancy risk factors for antepartum stillbirth in the United States. Obstet Gynecol. 2010;116(5):1119–26.

    Article  PubMed  Google Scholar 

  21. Fretts RC, Elkin EB, Myers ER, Heffner LJ. Should older women have antepartum testing to prevent unexplained stillbirth? Obstet Gynecol. 2004;104:56–64.

    Article  PubMed  Google Scholar 

  22. Coletta J, Simpson LL. Maternal medical disease and stillbirth. Maternal medical disease and stillbirth. Clin Obstet Gynecol. 2010;53:607–16.

    Article  PubMed  Google Scholar 

  23. Sheiner E, Shoham-Vardi I, Hershkovitz R, Katz M, Mazor M. Infertility treatment is an independent risk factor for cesarean section among nulliparous women aged 40 and above. Am J Obstet Gynecol. 2001;185(4): 888–92.

    Article  PubMed  CAS  Google Scholar 

  24. Bell JS, et al. Do obstetrics complications explain high cesarean section rates among women over 30? A retrospective analysis. BMJ. 2001;322:894–5.

    Article  PubMed  CAS  Google Scholar 

  25. Ranke MB, Saenger P. Turner’s syndrome. Lancet. 2001;358:309–14.

    Article  PubMed  CAS  Google Scholar 

  26. Bondy C. Congenital cardiovascular disease in Turner syndrome. Congenit Heart Dis. 2008;3:2–15.

    Article  PubMed  Google Scholar 

  27. Foudila T, Soderstrom-Anttila V, Hovatta O. Turner’s syndrome and pregnancies after oocyte donation. Hum Reprod. 1999;14(2):532–5.

    Article  PubMed  CAS  Google Scholar 

  28. Boissonnas C, et al. Careful cardiovascular screening and follow-up of women with Turner syndrome before and during pregnancy is necessary to prevent maternal mortality. Fertil Steril. 2009;91(3):929.e5–e7.

    Article  Google Scholar 

  29. Khastgir G, et al. Oocyte donation in Turner’s syndrome: an analysis of the factors affecting outcome. Hum Reprod. 1997;12(2):279–85.

    Article  PubMed  CAS  Google Scholar 

  30. Bodri D, et al. Oocyte donation in patients with Turner’s syndrome: a successful technique but with an accompanying high risk of hypertensive disorders during pregnancy. Hum Reprod. 2006;21(3):829–32.

    Article  PubMed  CAS  Google Scholar 

  31. Hovatta O. Pregnancies in women with Turner’s syndrome. Ann Med. 1999;31:106–10.

    PubMed  CAS  Google Scholar 

  32. Immer FF, et al. Aortic dissection in pregnancy: analysis of risk factors and outcome. Ann Thorac Surg. 2003;76:309.

    Article  PubMed  Google Scholar 

  33. Karnis MF. The risk of oocyte donation in patients with Turner syndrome. Int Cong Ser. 2006;1298: 190–5.

    Article  Google Scholar 

  34. Beauchesne LM, Connolly HM, Ammash NM, Warnes CA. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol. 2001;38:1728–33.

    Article  PubMed  CAS  Google Scholar 

  35. Karnis MF, et al. Risk of death in pregnancy achieved through oocyte donation in patients with Turner syndrome: a national survey. Fertil Steril. 2003;80(3): 498–501.

    Article  PubMed  Google Scholar 

  36. The Practice Committee of the American Society for Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril. 2008;90(3 Suppl):S185–6.

    Google Scholar 

  37. Kavic SM, Sauer MV. Oocyte donation treats infertility in survivors of malignancies: ten-year experience. J Assist Reprod Genet. 2001;18(3):181–3.

    PubMed  CAS  Google Scholar 

  38. Anselmo AP, et al. Successful pregnancies following an egg donation program in women with previously treated Hodgkin’s disease. Haematol. 2001;86:624–8.

    CAS  Google Scholar 

  39. Sanders JE, et al. Pregnancies following high dose cyclophosphamide with or without high dose busulfan or total body irradiation and bone marrow transplantation. Blood. 1996;87:3045–52.

    PubMed  CAS  Google Scholar 

  40. Critchley H. Factors of importance for implantation and problems after treatment for childhood cancer. Med Pediatr Oncol. 1999;33:9–14.

    Article  PubMed  CAS  Google Scholar 

  41. Noyes N, Knopman JM, Long K, Coletta JM, Abu-Rustum NR. Fertility considerations in the management of gynecologic malignancies. Gynecol Oncol. 2011;120:326–33.

    Article  PubMed  Google Scholar 

  42. Abdalla HA, et al. Obstetric outcome in 232 oocyte donation pregnancies. Br J Obstet Gynaecol. 1998;105:332–7.

    Article  PubMed  CAS  Google Scholar 

  43. Greenfeld D. Psychosocial aspects of oocyte donation in older couples. Curr Opin Obstet Gynecol. 2011;23:206–9.

    Article  PubMed  Google Scholar 

  44. Klein J, Sauer M. Oocyte donation. Best Pract Res Clin Obstet Gynaecol. 2002;16(3):277–91.

    Article  PubMed  Google Scholar 

  45. Herschberger P. Recipients of oocyte donation: an integrative review. J Obstet Gynecol Neonatal Nurs. 2004;33(5):610–21.

    Article  Google Scholar 

  46. Raoul-Duval A, Letur-Konirsch H, Frydman R. Anonymous oocyte donation: a psychological study of recipients, donors and children. Hum Reprod. 1992;7(1):51–4.

    PubMed  CAS  Google Scholar 

  47. Kort DH, Gosselin JG, Choi JM, Thornton MH, Cleary-Goldman J, Sauer MV. Pregnancy after 50: defining risks for mother and child. Am J Perinatol. 2012;29:245–50.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York Presbyterian Hospital-Columbia University Medical Center, 622 West 168th Street, PH-16, New York, NY, 10032, USA

    Zachary S. Rubeo M.D.

  2. Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York Presbyterian Hospital-Columbia University Medical Center, 622 West 168th Street, PH-16, New York, NY, 10510, USA

    Lynn L. Simpson M.D.

Authors
  1. Zachary S. Rubeo M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lynn L. Simpson M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lynn L. Simpson M.D. .

Editor information

Editors and Affiliations

  1. , Center for Women’s Reproductive Care, Columbia University, 1790 Broadway, New York, 10019, New York, USA

    Mark V. Sauer

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Rubeo, Z.S., Simpson, L.L. (2013). Prenatal Considerations After Oocyte Donation. In: Sauer, M. (eds) Principles of Oocyte and Embryo Donation. Springer, London. https://doi.org/10.1007/978-1-4471-2392-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2392-7_13

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2391-0

  • Online ISBN: 978-1-4471-2392-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation